Barclays: Maintaining the Gilead Sciences (GILD.US) rating, adjusted from a shareholding wait-and-see rating to a shareholding wait-and-see rating, and the target price was adjusted from $80.00 to $76.00.
巴克莱：维持Gilead Sciences(GILD.US)评级，由持股观望调整至持股观望评级, 目标价由80.00美元调整至76.00美元。
Barclays: Maintaining the Gilead Sciences (GILD.US) rating, adjusted from a shareholding wait-and-see rating to a shareholding wait-and-see rating, and the target price was adjusted from $80.00 to $76.00.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.